These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1152348)

  • 21. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD; Wenger T; Smith TW; Lovejoy FH
    N Engl J Med; 1992 Jun; 326(26):1739-44. PubMed ID: 1594015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration.
    Smith TW; Haber E
    J Clin Invest; 1970 Dec; 49(12):2377-86. PubMed ID: 5480861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of digoxin determination by E.L.I.S.A. and radioimmunoassay techniques (author's transl)].
    Raichvarg D; Cazalet C; Scherrmann JM; Caillens H
    Toxicol Eur Res; 1979 May; 2(3):149-53. PubMed ID: 531886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid, simple assay for digoxin.
    Greenwood H; Howard M; Landon J
    J Clin Pathol; 1974 Jun; 27(6):490-4. PubMed ID: 4411728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negligible interference by spironolactone and prednisone in digoxin radioimmunoassay.
    Ravel R
    Clin Chem; 1975 Nov; 21(12):1801-3. PubMed ID: 1183001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digoxin radioimmunoassay: a comparison of the assay performances using tritiated and 125I radioiodinated tracers.
    Barbieri U; Gandolfi C
    Clin Chim Acta; 1977 Jun; 77(3):257-67. PubMed ID: 872427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some factors affecting a commercial kit for radioimmunoassay of digoxin using tritiated digoxin.
    Boink AB; Kruyswijk HH; Willebrands AF; Maas AH
    J Clin Chem Clin Biochem; 1977 May; 15(5):261-6. PubMed ID: 894193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digitalis pharmacokinetics and therapy with respect to impaired renal function.
    Kramer P
    Klin Wochenschr; 1977 Jan; 55(1):1-11. PubMed ID: 319291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [False results of measuring digoxin levels in patients with renal failure. Comparison of the RIA--FPIA methods].
    Jankowski A; Karwowski J; Marzec A; Kretowicz W; Nartowicz E
    Kardiol Pol; 1990 Feb; 33(2):116-21. PubMed ID: 2277482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radioimmune method of determining the concentration of digoxin in the blood during treatment of patients with cardiac insufficiency].
    Dobrotvorskaia TE; Cherniak MS; Grishutina KA
    Kardiologiia; 1976 Dec; 16(12):92-8. PubMed ID: 1011488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced variation of tracer binding in digoxin radioimmunoassay by use of (125I)-labeled tyrosine-methyl-ester derivative: relation of thyroxine concentration to binding.
    Kroening BH; Weintraub M
    Clin Chem; 1976 Oct; 22(10):1732-4. PubMed ID: 975522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross reactivity of digitoxin and spironolactone in two radioimmunoassays for serum digoxin.
    Müller H; Bräuer H; Resch B
    Clin Chem; 1978 Apr; 24(4):706-9. PubMed ID: 639280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical value of determination of digoxin concentration in blood during treatment of cardiac insufficiency].
    Naumov VG; Rossel's AN
    Kardiologiia; 1977 Sep; 17(9):34-9. PubMed ID: 926597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between digoxin-induced cardiac arrhythmias and serum-digoxin levels (author's transl)].
    Hennersdorf G; Mariss P; Biermann S; Haindl H; Lichtlen P
    Dtsch Med Wochenschr; 1977 Mar; 102(11):381-4. PubMed ID: 66122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radionuclide methods of determining digoxin levels].
    Trusov VV; Zelenin AA
    Med Radiol (Mosk); 1983 Aug; 28(8):57-60. PubMed ID: 6888212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spironolactone as a source of interference in commercial digoxin immunoassays.
    Morris RG; Lagnado PY; Lehmann DR; Frewin DB; Glistak ML; Burnet RB
    Ther Drug Monit; 1987 Jun; 9(2):208-11. PubMed ID: 3617160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum digoxin levels using an 125I-labelled antigen: Validation of method and observations on cardiac patients.
    Taubert K; Shapiro W
    Am Heart J; 1975 Jan; 89(1):79-86. PubMed ID: 1109556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precision of digoxin radioimmunoassays and matrix effects: four kits compared.
    Bergdähl B; Molin L
    Clin Biochem; 1981 Apr; 14(2):67-71. PubMed ID: 7296815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of digoxin in serum. Comparison of radioimmunoassay and a heterogeneous enzyme immunoassay (author's transl)].
    Borner K; Rietbrock N
    J Clin Chem Clin Biochem; 1978 Jun; 16(6):335-42. PubMed ID: 353220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experiences with the determination of the plasma digoxin level].
    Jambroes G; Kruyswijk HH; Boink AB; Maas AH; Willebrands AF
    Ned Tijdschr Geneeskd; 1973 Dec; 117(48):1802-8. PubMed ID: 4788672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.